Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 2
1955 2
1956 2
1957 1
1958 4
1959 13
1960 3
1961 4
1962 9
1963 13
1964 10
1965 18
1966 29
1967 19
1968 33
1969 31
1970 37
1971 29
1972 44
1973 50
1974 69
1975 43
1976 38
1977 66
1978 72
1979 92
1980 90
1981 77
1982 96
1983 121
1984 101
1985 112
1986 120
1987 127
1988 177
1989 178
1990 168
1991 187
1992 168
1993 189
1994 210
1995 219
1996 220
1997 246
1998 240
1999 237
2000 218
2001 215
2002 228
2003 261
2004 259
2005 297
2006 288
2007 303
2008 308
2009 385
2010 352
2011 356
2012 419
2013 436
2014 494
2015 495
2016 505
2017 546
2018 568
2019 573
2020 671
2021 718
2022 618
2023 547
2024 280

Text availability

Article attribute

Article type

Publication date

Search Results

13,042 results

Results by year

Filters applied: . Clear all
Page 1
PIM1 controls GBP1 activity to limit self-damage and to guard against pathogen infection.
Fisch D, Pfleiderer MM, Anastasakou E, Mackie GM, Wendt F, Liu X, Clough B, Lara-Reyna S, Encheva V, Snijders AP, Bando H, Yamamoto M, Beggs AD, Mercer J, Shenoy AR, Wollscheid B, Maslowski KM, Galej WP, Frickel EM. Fisch D, et al. Among authors: yamamoto m. Science. 2023 Oct 6;382(6666):eadg2253. doi: 10.1126/science.adg2253. Epub 2023 Oct 6. Science. 2023. PMID: 37797010 Free PMC article.
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Van Mieghem NM, Unverdorben M, Hengstenberg C, Möllmann H, Mehran R, López-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rodés-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD; ENVISAGE-TAVI AF Investigators. Van Mieghem NM, et al. Among authors: yamamoto m. N Engl J Med. 2021 Dec 2;385(23):2150-2160. doi: 10.1056/NEJMoa2111016. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449183 Clinical Trial.
StayGold variants for molecular fusion and membrane-targeting applications.
Ando R, Shimozono S, Ago H, Takagi M, Sugiyama M, Kurokawa H, Hirano M, Niino Y, Ueno G, Ishidate F, Fujiwara T, Okada Y, Yamamoto M, Miyawaki A. Ando R, et al. Among authors: yamamoto m. Nat Methods. 2024 Apr;21(4):648-656. doi: 10.1038/s41592-023-02085-6. Epub 2023 Nov 30. Nat Methods. 2024. PMID: 38036853 Free PMC article.
Safety and stable survival of stem-cell-derived retinal organoid for 2 years in patients with retinitis pigmentosa.
Hirami Y, Mandai M, Sugita S, Maeda A, Maeda T, Yamamoto M, Uyama H, Yokota S, Fujihara M, Igeta M, Daimon T, Fujita K, Ito T, Shibatani N, Morinaga C, Hayama T, Nakamura A, Ueyama K, Ono K, Ohara H, Fujiwara M, Yamasaki S, Watari K, Bando K, Kawabe K, Ikeda A, Kimura T, Kuwahara A, Takahashi M, Kurimoto Y. Hirami Y, et al. Among authors: yamamoto m. Cell Stem Cell. 2023 Dec 7;30(12):1585-1596.e6. doi: 10.1016/j.stem.2023.11.004. Cell Stem Cell. 2023. PMID: 38065067
Nrf2 activation improves experimental rheumatoid arthritis.
Zhang A, Suzuki T, Adachi S, Yoshida E, Sakaguchi S, Yamamoto M. Zhang A, et al. Among authors: yamamoto m. Free Radic Biol Med. 2023 Oct;207:279-295. doi: 10.1016/j.freeradbiomed.2023.07.016. Epub 2023 Jul 24. Free Radic Biol Med. 2023. PMID: 37494986 Free article.
Retinal ferroptosis as a critical mechanism for the induction of retinochoroiditis during ocular toxoplasmosis.
Yamada K, Tazaki A, Ushio-Watanabe N, Usui Y, Takeda A, Matsunaga M, Suzumura A, Shimizu H, Zheng H, Ariefta NR, Yamamoto M, Hara H, Goto H, Sonoda KH, Nishiguchi KM, Kato M, Nishikawa Y, Toyokuni S, Kaneko H. Yamada K, et al. Among authors: yamamoto m. Redox Biol. 2023 Nov;67:102890. doi: 10.1016/j.redox.2023.102890. Epub 2023 Sep 17. Redox Biol. 2023. PMID: 37738924 Free PMC article.
Current status and future perspectives for the treatment of resectable locally advanced esophagogastric junction cancer: A narrative review.
Shoji Y, Koyanagi K, Kanamori K, Tajima K, Ogimi M, Yatabe K, Yamamoto M, Kazuno A, Nabeshima K, Nakamura K, Nishi T, Mori M. Shoji Y, et al. Among authors: yamamoto m. World J Gastroenterol. 2023 Jun 28;29(24):3758-3769. doi: 10.3748/wjg.v29.i24.3758. World J Gastroenterol. 2023. PMID: 37426325 Free PMC article. Review.
Insights into the Regulation of GFR by the Keap1-Nrf2 Pathway.
Kidokoro K, Kadoya H, Cherney DZI, Kondo M, Wada Y, Umeno R, Kishi S, Nagasu H, Nagai K, Suzuki T, Sasaki T, Yamamoto M, Kanwar YS, Kashihara N. Kidokoro K, et al. Among authors: yamamoto m. Kidney360. 2023 Oct 1;4(10):1454-1466. doi: 10.34067/KID.0000000000000171. Epub 2023 Jun 2. Kidney360. 2023. PMID: 37265366 Free PMC article.
Prolonged platelet hyperactivity after COVID-19 infection.
Nara N, Shimizu M, Yamamoto M, Nakamizo T, Hayakawa A, Johkura K. Nara N, et al. Among authors: yamamoto m. Br J Haematol. 2024 Feb;204(2):492-496. doi: 10.1111/bjh.19125. Epub 2023 Oct 11. Br J Haematol. 2024. PMID: 37822090
13,042 results
You have reached the last available page of results. Please see the User Guide for more information.